L/E-TECDAX TR EUR/ DE0001717072
TDXL12/8/2023 9:00:00 AM | Chg. -8.03 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
3,211.93XXP | -0.25% | 3,219.96 | 3,219.96 | 3,208.63 | 3,219.96 |
pressetext
4/27
PTA-News: Software AG: Software AG reports Digital Business ARR growth of 21 percent; confirms full-...
pressetext
9/11/2018
PTA-News: Medigene AG: Medigene participates at further conferences in September
pressetext
8/7/2018
PTA-News: Medigene AG: Medigene Reports Results for the First Half of 2018<BR/>Conference call and w...
pressetext
7/2/2018
PTA-News: Medigene AG: Medigene presents at upcoming conferences<BR/>Medigene presents at upcoming c...
pressetext
4/19/2018
PTA-News: Medigene AG: Medigene presents data on the successful production of AML DC vaccines at AAC...
pressetext
4/17/2018
PTA-News: Medigene AG: Clinical data for DC vaccine in prostate cancer IIT study presented by Oslo U...
pressetext
4/11/2018
PTA-News: Medigene AG: Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO...
pressetext
2/26/2018
PTA-News: Medigene AG: Medigene announces participation at four upcoming conferences
pressetext
1/19/2018
PTA-News: Medigene AG: Medigene announces participation at six upcoming investor and scientific conf...
pressetext
12/5/2017
PTA-Adhoc: Medigene AG: Medigene sells US-rights for Veregen® and raises financial guidance 2017
pressetext
12/4/2017
PTA-News: Medigene AG: Medigene announces participation at upcoming investor and scientific conferen...
pressetext
11/27/2017
PTA-News: Medigene AG: Patient recruitment completed for Phase I/II DC vaccine trial in AML
pressetext
10/11/2017
PTA-News: Medigene AG: Medigene and academic partners publish a method to identify T cell receptors ...